πŸ‡ΊπŸ‡Έ FDA
Patent

US 7728017

Inhibitors of c-Met and uses thereof

granted A61PA61P35/00A61P35/02

Quick answer

US patent 7728017 (Inhibitors of c-Met and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P35/00, A61P35/02, A61P35/04, A61P43/00